![Dmitry Soloviev](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Pavel Shashkov | M | 66 |
Cambridge Oncometrix Ltd.
![]() Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | - |
Maxim Rossmann | M | - |
Cambridge Oncometrix Ltd.
![]() Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | - |
Irina Soltamova Solovyev | F | - |
Cambridge Oncometrix Ltd.
![]() Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | - |
Erwin Wolf | M | 70 |
Cambridge Oncometrix Ltd.
![]() Cambridge Oncometrix Ltd. Medical SpecialtiesHealth Technology Cambridge Oncometrix Ltd. engages in the development of prostate cancer risk stratification test solutions. Its non-invasive pre-biopsy diagnostic test allows for improved prostate cancer risk assessment in primary and secondary care. The company was founded by Maxim Rossmann, Dmitry Soloviev, Irina Soltamova Solovyev, and Pavel Shashkov and is headquartered in Norwich, the United Kingdom. | 5 anni |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 4 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Dmitry Soloviev
- Contatti personali